Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
- The submission file is prepared as per instructions in the Author Guidelines.
- This is an original work of the authors and contains no copyright violations or plagiarism.
- This submission has the concurrence of all authors of the work.
The approximate length of article should preferably be less than 3000 words (excluding Abstract and References). Original research articles should include a structured abstract (of 200 words maximum) under four subheadings: (i) Background & objectives, (ii) Methods, (iii) Results, and (iv) Interpretation & conclusions, followed by 3-8 key words arranged alphabetically. The main article should include the sections in following order: Introduction, Material & Methods, Results, Discussion, Acknowledgement (if any), Conflicts of Interest and References. The permission from the Ethics Committee/ Institutional Review Board (IRB) is mandatory for all studies on human subjects and animals and this should be mentioned in the Material & Methods section. Registration of clinical trials is mandatory and registration number/CTR number should be mentioned. Maximum number of references should be less than 40.
Systematic Reviews Including Meta-analysis. The articles under this section will be critical appraisal of different studies on important topics of clinical/public health significance to obtain an unbiased quantitative estimate of the overall effect of an intervention or variable for a defined outcome. The focus could be on cause, diagnosis, prognosis, therapy, prevention, etc. These would be thoroughly researched articles giving a comprehensive and balanced perspective. There should be a structured abstract. Systematic reviews should be preferably less than 4000 words with a minimum number of Tables/Figures. These will be published subject to peer review. Maximum number of references could be upto 75.
Case Report / Case Series
New, interesting and rare cases can be reported. They should be unique, describing a great diagnostic or therapeutic challenge and providing a learning point for the readers. Cases with clinical significance or implications will be given priority. These communications could be of up to 1000 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured), Key-words, Introduction, Case report, Discussion, Reference, Tables and Legends in that order; and could be supported with up to 10 references. Case Reports could be authored by up to four authors. For accepted Case Reports, time to publication may be higher depending upon the backlog. Maximum number of references should be less than 20.
These are primarily opinion pieces written by senior scientists, public health experts and policy makers. Such papers will be generally written by a single author. No anonymous articles will be published. These should be about 1000-1500 words and should contain references. Except for commissioned pieces, all submissions will be published subject to peer review. Maximum number of references should be less than 20.
These should be short and decisive observations. They should preferably be related to articles previously published in the Journal or views expressed in the journal (except these articles: Editorial / Guest Editorial / Editorial Commentary). They should not be preliminary observations that need a later paper for validation. The letter could have up to 500-700 words and 10 references. It could be generally authored by not more than four authors.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgment of its initial publication in this journal.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.